Shareholders meeting

Viyash Scientific Limited (Formerly known as Sequent Scientific Limited) Registered Office: 3rd Floor, Srivalli’s Corporate, Plot No.290, Road No.6, Sy.No.33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India-500033 T: +91 40 23635000, E: investorrelations@viyash.com Website: www.viyash.com CIN: L99999TS1985PLC196357 Date: July 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 001. Mumbai - 400 051. Scrip code: 512529 Symbol: VIYASH Subject: Notice of 41st Annual General Meeting (“AGM”) and Annual Report for the FY 2025‐26 Pursuant to Regulation 30 and 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following document for your reference: a) The Notice of the 41st AGM Following is the key information regarding the 41st Annual General Meeting: 1. The Annual General Meeting is scheduled to be held on Tuesday, August 11, 2026, at 4.00 p.m. (IST) through Video Conferencing / Other Audio-Visual Means. 2. The Notice of the Annual General Meeting is available on the Company’s website at www.viyahs.com. The same can be accessed at Annual-Report-FY-2025-26.cd0a92331d1ea4dcf783.pdf . 3. The Company has provided the e-voting facility to its shareholders to exercise their voting rights on the resolutions set forth in the AGM Notice 4. The cut-off date for determining the eligibility to vote by remote e-voting or by e-voting system at the AGM shall be Tuesday, August 04, 2026. Details of the remote e-voting are as under: Remote E-voting start time and date 9:00 A.M. (IST) on Friday, August 7, 2026 Remote E-voting end time and date 5:00 P.M. (IST) on Monday, August 10, 2026 5. The e-voting facility will also be available during the AGM. Shareholders attending the AGM through VC facility who are unable cast their vote by remote e-voting will be able to vote during the AGM You are requested to kindly take the same on record. Thanking you. Yours faithfully, For Viyash Scientific Limited (Formerly known as Sequent Scientific Limited) Yoshita Vora Company Secretary Encl/- Viyash Scientific Limited Annual Report 20(cid:368)(cid:371)(cid:17)(cid:368)(cid:372) Viyash Scientific Limited (formerly known as Sequent Scientific Limited) Regd. Office: 3rd Floor, Srivalli’s Corporate, Plot No. 290, SYN 33 34P TO 39, Guttala Begumpet, Jubilee Hills, Hyderabad - 500033, Telangana, India. Tel. No.: 91 040 23635000 | CIN: L99999TS1985PLC196357 Website: www.viyash.com | (cid:41)(cid:17)(cid:81)(cid:69)(cid:77)(cid:80)(cid:30)(cid:4)investorrelations@viyash.com (cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7) NOTICE is hereby given that the 41st (Forty First) Annual General Meeting (“AGM”) of the Members of Viyash Scientific Limited (formerly known as Sequent Scientific Limited) (the “Company”) will be held on Tuesday, August 11, 2026, at 4.00 p.m. (IST) through video conferencing (“VC”) / other audio visual means (“OAVM”), to transact the following businesses: Ordinary Business: (cid:45)(cid:88)(cid:73)(cid:81)(cid:4)(cid:50)(cid:83)(cid:18)(cid:4)(cid:367)(cid:30)(cid:4)(cid:37)(cid:72)(cid:83)(cid:84)(cid:88)(cid:77)(cid:83)(cid:82)(cid:4)(cid:83)(cid:74)(cid:4)(cid:37)(cid:89)(cid:72)(cid:77)(cid:88)(cid:73)(cid:72)(cid:4)(cid:42)(cid:77)(cid:82)(cid:69)(cid:82)(cid:71)(cid:77)(cid:69)(cid:80)(cid:4)(cid:55)(cid:88)(cid:69)(cid:88)(cid:73)(cid:81)(cid:73)(cid:82)(cid:88)(cid:87)(cid:4)(cid:83)(cid:74)(cid:4)(cid:88)(cid:76)(cid:73)(cid:4)(cid:39)(cid:83)(cid:81)(cid:84)(cid:69)(cid:82)(cid:93)(cid:4)(cid:74)(cid:83)(cid:86)(cid:4)(cid:88)(cid:76)(cid:73)(cid:4)(cid:74)(cid:77)(cid:82)(cid:69)(cid:82)(cid:71)(cid:77)(cid:69)(cid:80)(cid:4)(cid:93)(cid:73)(cid:69)(cid:86)(cid:4)(cid:73)(cid:82)(cid:72)(cid:73)(cid:72)(cid:4)(cid:49)(cid:69)(cid:86)(cid:71)(cid:76)(cid:4)(cid:369)(cid:367)(cid:16)(cid:4)(cid:368)(cid:366)(cid:368)(cid:372)(cid:30) To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereon be and are hereby received, considered and adopted. RESOLVED THAT the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the report of the Auditors thereon be and are hereby received, considered and adopted.” (cid:45)(cid:88)(cid:73)(cid:81)(cid:4)(cid:50)(cid:83)(cid:18)(cid:4)(cid:368)(cid:30)(cid:4)(cid:54)(cid:73)(cid:17)(cid:69)(cid:84)(cid:84)(cid:83)(cid:77)(cid:82)(cid:88)(cid:81)(cid:73)(cid:82)(cid:88)(cid:4)(cid:83)(cid:74)(cid:4)(cid:40)(cid:77)(cid:86)(cid:73)(cid:71)(cid:88)(cid:83)(cid:86)(cid:30) To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions, if any, of the Companies Act, 2013 read with the Companies (Appointment and Qualification of Directors) Rules, 2014 and Articles of Association of the Company, approval of the Members of the Company be and is hereby accorded to the re-appointment of Dr. Haribabu Bodepudi (DIN:01119687), Managing Director and Group CEO, who retires from office by rotation and being eligible, offers himself for re-appointment, liable to retire by rotation. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds and things and take all such steps as may be necessary, proper or expedient to give effect to this resolution.” (cid:45)(cid:88)(cid:73)(cid:81)(cid:4)(cid:50)(cid:83)(cid:18)(cid:4)(cid:369)(cid:30)(cid:4)(cid:54)(cid:73)(cid:17)(cid:69)(cid:84)(cid:84)(cid:83)(cid:77)(cid:82)(cid:88)(cid:81)(cid:73)(cid:82)(cid:88)(cid:4)(cid:83)(cid:74)(cid:4)(cid:40)(cid:77)(cid:86)(cid:73)(cid:71)(cid:88)(cid:83)(cid:86)(cid:30) To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions, if any, of the Companies Act, 2013 read with the Companies (Appointment and Qualification of Directors) Rules, 2014 and Articles of Association of the Company, approval of the Members of the Company be and is hereby accorded to the re-appointment of Mr. Rajaram Narayanan (DIN:02977405), Whole-time Director and CEO - Animal Health, who retires from office by rotation and being eligible, offers himself for re-appointment, liable to retire by rotation. RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds and things and take all such steps as may be necessary, proper or expedient to give effect to this resolution.” Special Business: (cid:45)(cid:88)(cid:73)(cid:81)(cid:4)(cid:50)(cid:83)(cid:18)(cid:4)(cid:370)(cid:30)(cid:4)(cid:54)(cid:69)(cid:88)(cid:77)(cid:74)(cid:77)(cid:71)(cid:69)(cid:88)(cid:77)(cid:83)(cid:82)(cid:4)(cid:83)(cid:74)(cid:4)(cid:86)(cid:73)(cid:90)(cid:77)(cid:87)(cid:73)(cid:72)(cid:4)(cid:86)(cid:73)(cid:81)(cid:89)(cid:82)(cid:73)(cid:86)(cid:69)(cid:88)(cid:77)(cid:83)(cid:82)(cid:4)(cid:84)(cid:69)(cid:93)(cid:69)(cid:70)(cid:80)(cid:73)(cid:4)(cid:88)(cid:83)(cid:4)(cid:88)(cid:76)(cid:73)(cid:4)(cid:39)(cid:83)(cid:87)(cid:88)(cid:4)(cid:37)(cid:89)(cid:72)(cid:77)(cid:88)(cid:83)(cid:86)(cid:4)(cid:74)(cid:83)(cid:86)(cid:4)(cid:88)(cid:76)(cid:73)(cid:4)(cid:74)(cid:77)(cid:82)(cid:69)(cid:82)(cid:71)(cid:77)(cid:69)(cid:80)(cid:4)(cid:93)(cid:73)(cid:69)(cid:86)(cid:4)(cid:368)(cid:366)(cid:368)(cid:371)(cid:17)(cid:368)(cid:366)(cid:368)(cid:372)(cid:30) To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, if any, of t [Showing first 8,000 characters — download PDF for full document]